Trial Profile
A phase IIa trial of ETS 6103 in patients with severe major depressive disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2011
Price :
$35
*
At a glance
- Drugs Tramadol (Primary) ; Amitriptyline
- Indications Major depressive disorder
- Focus Therapeutic Use
- 28 Jul 2011 New trial record